Wesbanco Bank Inc. Purchases 20,000 Shares of Phreesia, Inc. (NYSE:PHR)

Wesbanco Bank Inc. boosted its position in Phreesia, Inc. (NYSE:PHR) by 76.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 46,000 shares of the company’s stock after acquiring an additional 20,000 shares during the period. Wesbanco Bank Inc.’s holdings in Phreesia were worth $1,157,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. International Assets Investment Management LLC grew its stake in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the last quarter. Point72 DIFC Ltd purchased a new stake in Phreesia in the 2nd quarter worth approximately $209,000. XTX Topco Ltd bought a new stake in shares of Phreesia in the 3rd quarter worth approximately $247,000. Hsbc Holdings PLC bought a new stake in shares of Phreesia in the 2nd quarter worth approximately $301,000. Finally, Intech Investment Management LLC purchased a new position in shares of Phreesia during the third quarter valued at approximately $316,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total transaction of $86,955.60. Following the transaction, the general counsel now owns 116,296 shares in the company, valued at approximately $2,893,444.48. This represents a 2.92 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Amy Beth Vanduyn sold 25,447 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71. Following the sale, the senior vice president now directly owns 93,470 shares in the company, valued at approximately $1,956,327.10. The trade was a 21.40 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 131,756 shares of company stock worth $3,244,909. Corporate insiders own 5.80% of the company’s stock.

Phreesia Stock Up 0.2 %

Shares of NYSE:PHR opened at $27.26 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a fifty day simple moving average of $23.87 and a two-hundred day simple moving average of $22.97. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $29.16. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.55 and a beta of 0.94.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter in the previous year, the firm earned ($0.58) EPS. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently weighed in on PHR shares. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Citigroup raised their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Finally, Robert W. Baird reduced their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.